The latest price target for Helmerich & Payne (NYSE:HP) was reported by Goldman Sachs on June 4, 2026. The analyst firm set a price target for $41.00 expecting HP to rise to within 12 months (a possible 3.71% upside). 38 analyst firms have reported ratings in the last year.

The latest analyst rating for Helmerich & Payne (NYSE:HP) was provided by Goldman Sachs, and Helmerich & Payne maintained their neutral rating.

The last upgrade for Helmerich & Payne Inc happened on December 18, 2025 when Piper Sandler raised their price target to $35. Piper Sandler previously had a neutral for Helmerich & Payne Inc.

The last downgrade for Helmerich & Payne Inc happened on May 19, 2025 when Citigroup changed their price target from $25 to $19 for Helmerich & Payne Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Helmerich & Payne, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Helmerich & Payne was filed on June 4, 2026 so you should expect the next rating to be made available sometime around June 4, 2027.

While ratings are subjective and will change, the latest Helmerich & Payne (HP) rating was a maintained with a price target of $35.00 to $41.00. The current price Helmerich & Payne (HP) is trading at is $39.53, which is within the analyst’s predicted range.